
Adline Chem Lab Limited Appoints Vrushank Balkrushna Patel as Chairman and Managing Director
Adline Chem Lab Limited (formerly Kamron Laboratories Limited) announced on March 19, 2026, that the Board of Directors has approved the appointment of Mr. Vrushank Balkrushna Patel as Chairman and Managing Director. The appointment, previously approved by the Board on February 10, 2026, is subject to shareholder approval via Postal Ballot. Mr. Patel's term will be for a period of 5 years, effective February 10, 2026.The Board also approved the draft of the Postal Ballot Notice and Explanatory Statement, and appointed Mr. Ishit Vyas of M/s Ishit Vyas & Co. as Scrutinizer to conduct the Postal Ballot and remote e-voting process.
The Postal Ballot voting period will commence on March 26, 2026 (9:00 A.M. IST) and end on April 25, 2026 (5:00 P.M. IST). The cut-off date for identifying shareholders eligible to vote is March 20, 2026.
Mr. Patel holds an undergraduate degree in Civil Engineering from South Gujarat University and has over 12 years of experience in real estate development, manufacturing, green energy generation, and import/trading of natural resources. He is not related to any other director or key managerial personnel of the company. Further, he is not debarred from holding the office of Director by any SEBI order or other authority.
Key Details:
| Detail | Information |
|---|---|
| Appointment | Vrushank Balkrushna Patel |
| Position | Chairman and Managing Director |
| Date of Appointment | February 10, 2026 |
| Term | 5 years |
| Scrutinizer | Mr. Ishit Vyas of M/s Ishit Vyas & Co. |
| Remote E-voting Start Date | March 26, 2026 (9:00 A.M. IST) |
| Remote E-voting End Date | April 25, 2026 (5:00 P.M. IST) |
| Cut-off Date for Voting | March 20, 2026 |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.